Get started
Author

Jürgen Stoltefuß

Observed names: J Stoltefuss, J. STOLTEFUSS, J. Stoltefuss, J. Stoltefuß, JUERGEN STOLTEFUSS, Juergen Stoltefuss, Jürgen Stoltefuss, Jürgen Stoltefuss
Institution: Bayer (Germany)
OpenAlex ID: A5041630554
Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids
2003 · Karl Deres, Claus H. Schröder, et al. · Science · 519
1,4‐Dihydropyridines: Effects of Chirality and Conformation on the Calcium Antagonist and Calcium Agonist Activities
1991 · Siegfried Goldmann, Jürgen Stoltefuss · Angewandte Chemie International Edition in English · 455
Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model
2002 · O. Weber, K.-H. Schlemmer, et al. · Antiviral Research · 172
Determination of the absolute configuration of the active amlodipine enantiomer as (-)-S: a correction
1992 · Siegfried Goldmann, Juergen Stoltefuss, et al. · Journal of Medicinal Chemistry · 87
1,4‐Dihydropyridine: Einfluß von Chiralität und Konformation auf die Calcium‐antagonistische und ‐agonistische Wirkung
1991 · Siegfried Goldmann, Jürgen Stoltefuß · Angewandte Chemie · 59
Chemistry and Structure-Activity Relationships of Glucosidase Inhibitors
1996 · B. Junge, M. Matzke, et al. · Handbook of experimental pharmacology · 50
Stereoselective Mukaiyama-Michael/Michael/Aldol Domino Cyclization as the Key Step in the Synthesis of Pentasubstituted Arenes: An Efficient Access to Highly Active Inhibitors of Cholesteryl Ester Transfer Protein (CETP)
1999 · Holger Paulsen, Stefan Antons, et al. · Angewandte Chemie International Edition · 42
Pharmacologic and radioligand binding studies of 1,4-dihydropyridines in rat cardiac and vascular preparations: stereoselectivity and voltage dependence of antagonist and activator interactions.
1992 · W Zheng, J Stoltefuss, et al. · Molecular Pharmacology · 31
Umsetzungen von tert.‐Butyloxycarbonylfluorid mit trifunktionellen Aminosäuren
1971 · Eugen Schnabel, Jürgen Stoltefuß, et al. · Justus Liebig s Annalen der Chemie · 28
Acarbose ‐ ein neues Wirkprinzip in der Diabetestherapie
1994 · Hilmar Bischoff, Hans Jürgen Ahr, et al. · Nachrichten aus Chemie Technik und Laboratorium · 23
A new type of Ca-channel modulation by a novel class of 1,4-dihydropyridines
1996 · M. Bechem, S. Goldmann, et al. · Life Sciences · 22
Fluorine-Substitution in Cholesteryl Ester Transfer Protein Inhibitors (CETPInhibitors) – Biology, Chemistry, SAR, and Properties
2004 · Holger Paulsena, Siegfried Zaiss, et al. · CHIMIA International Journal for Chemistry · 9
PDF
Stereoselektive Mukaiyama-Michael/Michael/Aldol-Dominocyclisierung als Schlüsselschritt der Synthese pentasubstituierter Arene – ein effizienter Zugang zu hochwirksamen Inhibitoren des Cholesterinester-Transferproteins (CETP)
1999 · Holger Paulsen, Stefan Antons, et al. · Angewandte Chemie · 6
Chemistry of Dihydropyridines [1–4]
1985 · H. Meyer, E. Wehinger, et al. · Bayer-Symposium · 5
1,4-Dihydropyridines: Effects of Chirality and Conformation on Their Activity
1993 · S. Goldmann, J. Stoltefuß · Springer eBooks · 3
ChemInform Abstract: Stereoselective Mukaiyama—Michael/Michael/Aldol Domino Cyclization as the Key Step in the Synthesis of Pentasubstituted Arenes: An Efficient Access to Highly Active Inhibitors of Cholesteryl Ester Transfer Protein (CETP).
2000 · Holger Paulsen, Stefan Antons, et al. · ChemInform
ChemInform Abstract: Acarbose ‐ A New Active Substance in the Therapy of Diabetes
1995 · H. BISCHOFF, H. J. AHR, et al. · ChemInform
ChemInform Abstract: 1,4‐Dihydropyridines: Effects of Chirality and Conformation on the Calcium Antagonist and Calcium Agonist Activities
1992 · S. GOLDMANN, J. STOLTEFUSS · ChemInform
ChemInform Abstract: UMSETZUNGEN VON TERT.‐BUTYLOXYCARBONYL‐FLUORID MIT TRIFUNKTIONELLEN AMINOSAEUREN
1971 · EUGEN SCHNABEL, JUERGEN STOLTEFUSS, et al. · Chemischer Informationsdienst Organische Chemie
Works count: 19
Citation count: 1,511
H-index: 11
I10-index: 11
Year
Topic
Type